Exact Mass: 372.2736416

Deoxycorticosterone acetate (DOCA) is an adrenocortin, acts as a precursor to aldosterone. Deoxycorticosterone acetate is a mineralocorticoid receptor agonist. Deoxycorticosterone acetate can cause severe renal injury, including inflammation, fibrosis, glomerular damage, and proteinuria[1][2].

8,8a-Deoxyoleandolide

(3R,4S,5R,6S,7S,9R,11R,12S,13R,14R)-4,6,12-trihydroxy-3,5,7,9,11,13,14-heptamethyl-oxacyclotetradecane-2,10-dione

8,8a-Deoxyoleandolide is a naturally occurring sesquiterpene lactone, which is a type of organic compound derived from the metabolism of plants. It is characterized by the absence of an oxygen atom at the 8 and 8a positions in its molecular structure, which differentiates it from the related compound oleandolide. Sesquiterpene lactones are known for their biological activities, such as cytotoxic, anti-inflammatory, and antimicrobial properties. 8,8a-Deoxyoleandolide may be found in various plant species and could be of interest for pharmaceutical research due to its potential therapeutic effects. The compound's structure typically includes a lactone ring fused with a sesquiterpene framework, and it may exhibit various substituents depending on its source and the specific plant it is derived from. 13-Deethyl-6,12-dideoxy-13-methylerythronolide A. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=53428-54-9 (retrieved 2024-07-15) (CAS RN: 53428-54-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

16,17-Epoxypregnenolone acetate

16alpha,17alpha-Epoxy-20-oxopregn-5-en-3beta-yl acetate

3-Ethoxyandrosta-3,5-dien-17beta-ol propanoate

NCIOpen2_007953

3alpha-Hydroxy-5beta-pregn-16-ene-11,20-dione 3-acetate

Finasteride

(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide

Finasteride is only found in individuals that have used or taken this drug. Finasteride is an androgen antagonist. It is an orally active testosterone 5-alpha-reductase inhibitor. Finasteride is one of the currently available pharmacologic treatment modalities with proven efficacy for treatment of androgenetic alopecia. The mechanism of action has not been fully determined, but finasteride has shown to decrease scalp DHT concentration to the levels found in hairy scalp, reduce serum DHT, increase hair regrowth, and slow hair loss. Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50\\% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (e.g. finasteride), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Finasteride is also used as a surgical alternative for treatment of benign prostatic hyperplasia (PubChem). The mechanism of action of finasteride is based on its preferential inhibition of type II 5alpha-reductase through the formation of a stable complex with the enzyme. Inhibition of type II 5alpha-reductase blocks the peripheral conversion of testosterone to DHT (resulting in significant decreases in serum and tissue DHT concentrations), minimal to moderate increase in serum testosterone concentrations, and substantial increases in prostatic testosterone concentrations. As DHT appears to be the principal androgen responsible for stimulation of prostatic growth, a decrease in DHT concentrations will result in a decrease in prostatic volume (approximately 20-30\\% after 6-24 months of continued therapy). Finasteride may increase the sensitivity of prostate specific antigen to detect prostate cancer. At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer (PMID: 18044109, 17543725, 17414641, 17415094, 17394699). Finasteride is an androgen antagonist. Finasteride is one of the currently available pharmacologic treatment modalities with proven efficacy for treatment of androgenetic alopecia. Androgenetic alopecia (AGA), or male pattern hair loss, affects approximately 50\\% of the male population. AGA is an androgen-related condition in genetically predisposed individuals. There is no treatment to completely reverse AGA in advanced stages, but with medical treatment (e.g., finasteride), the progression can be arrested and partly reversed in the majority of patients who have mild to moderate AGA. Finasteride may increase the sensitivity of prostate specific antigen to detect prostate cancer. At present, finasteride remains the only intervention shown in long-term prospective phase III clinical trials to reduce the incidence of prostate cancer. (PMID: 18044109, 17543725, 17414641, 17415094, 17394699) [HMDB] G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000089162 - Genitourinary Agents > D064804 - Urological Agents C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent D - Dermatologicals

Gentian Violet

4-{bis[4-(dimethylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium

C25H30N3+ (372.24396)

Gentian Violet is only found in individuals that have used or taken this drug. It is a dye that is a mixture of violet rosanilinis with antibacterial, antifungal, and anthelmintic properties. [PubChem]In aqueous solutions Gentian violet (GV) dissociates into positive (GV+)and negative ions (Cl-) that penetrate through the wall and membrane of both gram-positive and gram-negative bacterial cells. The GV+ interacts with negatively charged components of bacterial cells including the lipopolysaccharide (on the cell wall), the peptidoglycan and DNA. A similar cell penetration and DNA binding process is thought to take place for fungal cells as well. Because Gentian violet is a mutagen and mitotic poison, cell growth is consequently inhibited. A photodynamic action of gentian violet, apparently mediated by a free-radical mechanism, has recently been described in bacteria and in the protozoan T. cruzi. Evidence also suggests that gentian violet dissipates the bacterial (and mitochondrial) membrane potential by inducing permeability. This is followed by respiratory inhibition. This anti-mitochondrial activity might explain gentian violets efficacy towards both bacteria and yeast with relatively mild effects on mammalian cells.

5-Ethoxysorgoleone 358

5-ethoxy-2-hydroxy-3-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]cyclohexa-2,5-diene-1,4-dione

5-Ethoxysorgoleone 358 is found in cereals and cereal products. 5-Ethoxysorgoleone 358 is a constituent of Sorghum bicolor (sorghum). Constituent of Sorghum bicolor (sorghum). 5-Ethoxysorgoleone 358 is found in cereals and cereal products.

(3R, 6'Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one

8-hydroxy-3-[(6E)-pentadec-6-en-1-yl]-3,4-dihydro-1H-2-benzopyran-1-one

(3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is found in fats and oils. (3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is a constituent of the fruit of Ginkgo biloba (ginkgo). Constituent of the fruit of Ginkgo biloba (ginkgo). (3R, 6Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one is found in fats and oils and herbs and spices.

5-(10,13-Nonadecadienyl)-1,3-benzenediol

5-[(10E,13E)-nonadeca-10,13-dien-1-yl]benzene-1,3-diol

5-(10,13-Nonadecadienyl)-1,3-benzenediol is found in cereals and cereal products. 5-(10,13-Nonadecadienyl)-1,3-benzenediol is a constituent of wheat and rye flour. Constituent of wheat and rye flour. 5-(10,13-Nonadecadienyl)-1,3-benzenediol is found in cereals and cereal products.

Scutigeral

2,3,4-trihydroxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzaldehyde

Scutigeral is found in mushrooms. Scutigeral is a constituent of Albatrellus ovinus Constituent of Albatrellus ovinus. Scutigeral is found in mushrooms.

Nabilone

(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-9-one

Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC) but it has more predictable side effects and causes no or minimal euphoria. Nabilone is not derived from the cannabis plant as is dronabinol. In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the United States FDA for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS. Although it doesnt have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrate various benefits for condition such as fibromyalgia and multiple scerosis. Nabilone is a racemate consisting of the (S,S) and the (R,R) isomers (trans). A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

9'-Carboxy-gamma-tocotrienol

(2E,6E)-9-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-2-yl]-2,6-dimethylnona-2,6-dienoic acid

9-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Gamma-tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. Gamma-tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. 9-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 9-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate

Cervonoyl ethanolamide

2-Hydroxyethyl (7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid

Cervonoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB] Cervonoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249).

Neriantogenin

4-{5,12-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-13-en-14-yl}-2,5-dihydrofuran-2-one

Neriantogenin is a hydrolysis produced from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US Hydrolysis production from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.

1-Phenyl-1,3-nonadecanedione

1-phenylnonadecane-1,3-dione

1-Phenyl-1,3-nonadecanedione is found in fats and oils. 1-Phenyl-1,3-nonadecanedione is a constituent of the pollen of Helianthus annuus (sunflower) Constituent of the pollen of Helianthus annuus (sunflower). 1-Phenyl-1,3-nonadecanedione is found in fats and oils.

DG(8:0/10:0/0:0)

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] decanoate

DG(8:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/10:0)

[(2R)-2-hydroxy-3-octanoyloxypropyl] decanoate

DG(8:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(10:0/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl decanoate

DG(10:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(10:0/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl decanoate

DG(10:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

17alpha-Acetoxyprogesterone

14-Acetyl-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl acetic acid

Cesamet

1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-9-one

Deoxycorticosterone acetate

2-{2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl}-2-oxoethyl acetate

D000893 - Anti-Inflammatory Agents

Grifolic acid

2,4-dihydroxy-6-methyl-3-(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)benzoic acid

Norgestomet

14-acetyl-15,17-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl acetate

Prorenoate

3-(8-Hydroxy-5a,7a-dimethyl-3-oxo-1,1a,3,4,5,5a,5b,6,7,7a,8,9,10,10a,10b,10c-hexadecahydrocyclopenta[a]cyclopropa[l]phenanthren-8-yl)propanoic acid

[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] pentanoate

[(8S,9S,13S,14S,17R)-3,17-Dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-1-yl] pentanoic acid

Anemarsaponin BIII

Xysmalogenin

5,6-Dehydrouzarigenin

Ferutidin

Jaeschkeanadiol p-methoxybenzoate

Grifolic acid

2-[3-(furan-3-yl)propyl]-6-methyl-8-(2,6,6-trimethylcyclohex-2-en-1-yl)oct-5-en-1-ol

Kojistatin A

14-Hydroxy-12,13-dihydrosesquiterpineol-14-O-xylopyranoside

(+)-Hongoquercin A

Asperugin C

18-Hydroxy-5-epihyrtiophenol

3-Oxo-chol-4-en-24-oic acid

(+)-3-Oxo-chol-4-en-24-oic acid

Lipoxamycin

C19H36N2O5 (372.2624086)

[1R-(1alpha,4alpha,4aalpha,5alpha,6alpha,8abeta)]-Decahydro-4,8a-dimethyl-6-(1-methylethyl)-1,4-epoxynaphthalen-5-yl ester 4-methoxybenzoic acid

Strongylodiol H

Metachromin B

Dictyoceratin A

Neoenactin A

C19H36N2O5 (372.2624086)

20S-acetyloxy-4-pregnene-3,16-dione

18-hydroxyhyrtiophenol

Thromboxane B1

9S,11,15S-trihydroxy-thrombox-13E-enoic acid

MLS002693435

Chol-11-Enic Acid

nonadecadienylresorcinol

Malouphyllamin

Digirezigenin

Dysideapalaunic acid

metachromin T

A sesquiterpenoid that is 6,8-dimethoxy-2,2-dimethyl-2H-chromen-5-ol in which the hydrogen of one of the methyl groups at position 2 is replaced by a [(1R,2S)-1,2,3-trimethylcyclohex-3-en-1-yl]methyl group. It is isolated from an Okinawan sponge Spongia sp.SS-1037 and shows moderate cytotoxicity against L1210 murine leukemia and KB human epidermoid carcinoma cells.

3,6-Dihydroxy-2-(1-oxo-11-phenylundecyl)-3-cyclohexen-1-one

C23H32O4

Antibiotic LL-Z 1272epsilon

3,20-Dioxopregn-4-en-17-yl acetate

kohamaic acid|kohamaic acid A

DB-056517

CHEMBL550550

ilicicolinic acid B

20-O-acetyl-21-hydroxy-ent-isozonarol

lasidiol-10-anisate

3-oxo-uzarigenin|Odorigenon-B|odorigenone-B|uzarigenone

3beta-Hydroxy-24-methyl-chol-5-en-24-on|3beta-hydroxy-24-methyl-chol-5-en-24-one

3beta-dimethylamino-con-5-en-12beta-ol|Holarrhenine

F1839-I

emericolin B

(Z,Z)-3-(heptadeca-8,11-dienyl)-1,2-dimethoxybenzene|O-dimethyl-3-<8Z,11Z-heptadecadienyl>catechol

3beta,11alpha-Dihydroxy-5beta-carda-14,20(22)-dienolid|3beta,11alpha-dihydroxy-5beta-carda-14,20(22)-dienolide

dictyoceratin-A

juniferin

4-Ac-6-(3,7,11-Trimethyl-2,6,10-dodecatrienyl)-1,2,4-benzenetriol

Plakinic acid A

19-malonyloxy-dehydroabietinol

6-Hydroxy-5-acetyl-avarol

Ceralbol

C28 TRIAROMATIC STERANE

C28H36 (372.2816856)

Norvangiformsaeure

(4E,8E)-1-(2,4-dihydroxyphenyl)-2-hydroxy-5,9,13-trimethyltetradeca-4,8,12-trien-1-one|1-(2,4-dihydroxyphenyl)-2-hydroxy-5,9,13-trimethyl-4(E),8(E),12-tetradecatrien-1-one

C20H36O6

Smenorthoquinone

Ginkgolic acid C17:2

STL566143

3beta,5-Dihydroxy-5beta-carda-14,20(22)-dienolid|3beta,5-dihydroxy-5beta-carda-14,20(22)-dienolide|3beta,5beta-dihydroxy-14-en-card-20(22)-enolide

Methyl 3-hydroxy-9-oxo-9,10-seco-23,24-dinor-1,3,5(10)-cholatrien-22-oate

mycalenitrile-14

2alpha-Malonyloxy-abietatriene

AKOS024419604

2-Acetoxy-sugiylmethylaether

NSC527119

rhopaloic acid C

Me ester-19-Nor-15-prenyl-8,13,15-labdatrien-18-oic acid

Glyceryl monoricinoleate

2,3-Dihydroxypropyl 12-hydroxy-9-octadecenoate

Ac-12alpha-12-Hydroxypregn-4-ene-3,20-dione

Variculanol

4-O-(3,7-Dimethyl-2,6-octadienyl)---6-Demethylacronylin

16R-hydroxy-20-hexa-nor-cycloartenone

Oleagenin

(4R,6R,10R,12R)-4,10-dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|4R,6R,10R,12R,4,10-Dihydroxy-2,8-dioxo-6,12-dipentyl-1,7-dioxacyclododecane|Verbalactone

14-deoxy-15-isopropylidene-11,12-didehydroandrographolide

SCHEMBL22175819

Niuhinone A|niuhinone-A

20alpha-Acetoxypregn-4-en-3,16-dion|20S-acetyloxy-4-pregnen-3,16-dione|20S-acetyloxy-4-pregnene-3,16-dione

3,14-dihydroxycarda-16,20(22)-dienolide

Corotoxigenin

2-[(9Z,12Z)-heptadeca-9,12-dienyl]-6-hydroxybenzoic acid

stellettazole D

C22H36N4O (372.2888966)

2-farnesyl-3-hydroxy-4-methoxybenzoic acid

cananginone B

cananginone C

bendigole E

24-nor-7alpha,12alpha-dihydroxy-cholest-1,4-dien-3,22-dione

hollongdione

perovskatone A

3beta-acetoxypregn-20-en-19-oic acid|sclerosteroid D

3-((E)-4-hydroxy-3,7-dimethyl-octa-2,6-dienyl)-4-methoxy-5-(3-methyl-but-2-enyl)-benzoic acid

(6E,10E)-12-(2,5-dimethoxy-3-methylphenyl)-6,10-dimethyldodeca-6,10-dien-2,8-dione|cystoazorone A

dolabriferol B

1alpha,11beta-epoxy-4-humulen 6beta-p-anisate

heptadecane-1,2,3-tricarboxylic acid

DTXSID80938993

C24H36O3

3-Farnesyl-2,4,6-trihydroxyacetophenone

6alpha-hydroxyeudesm-4(15)-ene-9beta-O-anisate

strongylodiol B

BF-2

Hydroxy-2-pentadecyl-4H-1-benzopyran-4-one

Me ester-?藛1-Tetrahydrocannabinolic acid A

22-hydroxy-23,24,25,26,27-pentanorcucurbit-5-en-3-one|pentanorcucurbitacin A

NSC684579

smenodiol

16alpha,17-Epoxy-3xi-hydroxy-5xi,14xi-card-20(22)-enolid|16alpha,17-epoxy-3xi-hydroxy-5xi,14xi-card-20(22)-enolide

6-beta-vanilloyloxygermacra-1(10),4-diene

SCHEMBL21397174

Me ester-?藛1(6)-Tetrahydrocannabinolic acid A

4-Hydroxy-2-(11-phenylundecanoyl)-1,3-cyclohexanedione|4-hydroxy-2-(11-phenylundecanoyl)cyclohexane-1,3-dione

11,12-dimethoxy-abieta-6,8,11,13-tetraen-20-oic acid methyl ester|11,12-dimethoxyabieta-6,8,11,13-tetraen-20-oic acid methyl ester|6,7-didehydrocarnosic acid methyl ester dimethylether|Methyl 11,12-di-O-methyl-6,7-didehydrocarnosate

11,12-dimethoxy-abieta-6,8,11,13-tetraen-20-oic acid methyl ester|11,12-dimethoxyabieta-6,8,11,13-tetraen-20-oic acid methyl ester|6,7-didehydrocarnosic acid methyl ester dimethylether|Methyl 11,12-di-O-methyl-6,7-didehydrocarnosate

6-<(9Z,12Z)-heptadecadienyl>salicylic acid

C20H40N2O4 (372.29879200000005)

poecillanosine methyl ether

PETIOLIN B

Me ester-?藛1-Tetrahydrocannabinolic acid B

[1R-(1alpha,4alpha,4aalpha,5alpha,6alpha,8abeta)]-Decahydro-4,8a-dimethyl-6-(1-methylethyl)-1,4-epoxynaphthalen-5-yl ester 4-methoxybenzoic acid

Polycersoidin

methyl 16-acetoxy-8,11,13-abietatrien-18-oate

1-(3-Hydroxy-phenyl)-nonadec-10-en-2-on|1-(3-hydroxy-phenyl)-nonadec-10-en-2-one

DTXSID40702374

3beta,21alpha-Dimethoxyserrat-14-en

Pubescimine

1-(3-Hydroxy-phenyl)-nonadec-10c-en-2-on|1-(3-hydroxy-phenyl)-nonadec-10c-en-2-one

2-O-(9-hydroxyoctadec-cis-12-enoyl)glycerol

Ile Gln Ile

Asn Ile Leu

isoleucylisoleucyllysine

Asn Leu Ile

Leu Asn Ile

Gln Leu Val

Val Leu Gln

Leu Arg Ala

Ala Arg Leu

Ile Asn Leu

Lys Leu Val

Leu Gln Val

Ile Lys Ile

Arg Ala Leu

Val Gln Leu

Arg Leu Ala

Lys Val Leu

Leu Val Lys

Val Lys Leu

valylvalylarginine

Ala Leu Arg

Gln Ile Ile

Leu Ile Asn

Val Arg Val

Gln Val Leu

Leu Lys Val

Leu Val Gln

Ile Leu Asn

SCHEMBL15486905

Lys Ile Ile

Leu Ala Arg

Val Leu Lys

Ginkgolic acid 17:2

2-[(8E,11E)-heptadeca-8,11-dienyl]-6-hydroxybenzoic acid

(E/Z)-Ginkgolic acid C17:2, isolated from Ginkgo biloba, can bind with human dihydroorotate dehydrogenase (DHODH) tightly[1].

Crystal Violet

[C25H30N3]+ (372.24396)

[Raw Data] CB146_Crystal-violet_pos_50eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_40eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_30eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_20eV_CB000055.txt [Raw Data] CB146_Crystal-violet_pos_10eV_CB000055.txt

Finasteride

G - Genito urinary system and sex hormones > G04 - Urologicals > G04C - Drugs used in benign prostatic hypertrophy > G04CB - Testosterone-5-alpha reductase inhibitors D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D000089162 - Genitourinary Agents > D064804 - Urological Agents C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent D - Dermatologicals CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9164; ORIGINAL_PRECURSOR_SCAN_NO 9159 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9203; ORIGINAL_PRECURSOR_SCAN_NO 9201 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9222; ORIGINAL_PRECURSOR_SCAN_NO 9221 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9254; ORIGINAL_PRECURSOR_SCAN_NO 9252 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9266; ORIGINAL_PRECURSOR_SCAN_NO 9265 CONFIDENCE standard compound; INTERNAL_ID 541; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9274; ORIGINAL_PRECURSOR_SCAN_NO 9273 CONFIDENCE standard compound; INTERNAL_ID 2702 CONFIDENCE standard compound; INTERNAL_ID 4115

11α-Acetoxyprogesterone

11-alpha-Acetoxyprogesterone

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.305 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.306

MLS001165768-01!FINASTERIDE98319-26-7

MLS001074065-01!DEOXYCORTICOSTERONE ACETATE

2,4-dihydroxy-6-(hydroxymethyl)-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

NCGC00385473-01!2,4-dihydroxy-6-(hydroxymethyl)-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzaldehyde

2,4-dihydroxy-6-methyl-3-[(E)-3-methyl-5-[(1S,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]pent-2-enyl]benzaldehyde

NCGC00347806-02!2,4-dihydroxy-6-methyl-3-[(E)-3-methyl-5-[(1S,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]pent-2-enyl]benzaldehyde

C23H32O4_Carda-5,20(22)-dienolide, 3,14-dihydroxy-, (3beta,9xi)

NCGC00347770-02_C23H32O4_Carda-5,20(22)-dienolide, 3,14-dihydroxy-, (3beta,9xi)-

11A-Acetoxyprogesterone

Norrangiformic acid

6-hydroxy, 5-acetoxy aureol

TXB1

CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID STD_neg_MSMS_1min0155.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 30.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 20.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 10.0 eV within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 40.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 30.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ] CONFIDENCE standard compound; NATIVE_RUN_ID QExHF03_NM_0001325.mzML; PROCESSING averaging of repeated ion fragments at 20.0 NCE within 5 ppm window [MS, MS:1000575, mean of spectra, ]

Doca

Deoxycorticosterone acetate

Desoxycorticosterone Acetate

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D008901 - Mineralocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Deoxycorticosterone acetate (DOCA) is an adrenocortin, acts as a precursor to aldosterone. Deoxycorticosterone acetate is a mineralocorticoid receptor agonist. Deoxycorticosterone acetate can cause severe renal injury, including inflammation, fibrosis, glomerular damage, and proteinuria[1][2].

11A-Acetoxyprogesterone_41.9\\%

11A-Acetoxyprogesterone_major

Deoxycorticosterone

Deoxycorticosterone acetate

(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((8S,9S,10R,13R,14S,17R)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

(7R,9S,10R,13R,14S,17R)-7-hydroxy-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one

"(7R,9S,10R,13R,14S,17R)-7-hydroxy-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one"

Ala Ala Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-methylpentanamido]-3-methylbutanoic acid

Ala Ala Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-4-methylpentanamido]-3-methylbutanoic acid

Ala Ala Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-methylbutanamido]-3-methylpentanoic acid

Ala Ala Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-methylbutanamido]-4-methylpentanoic acid

Ala Gly Ile Ile

(2S,3S)-2-[(2S,3S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-methylpentanamido]-3-methylpentanoic acid

Ala Gly Ile Leu

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-methylpentanamido]-4-methylpentanoic acid

Ala Gly Leu Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-methylpentanamido]-3-methylpentanoic acid

Ala Gly Leu Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-methylpentanamido]-4-methylpentanoic acid

Ala Ile Ala Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]propanamido]-3-methylbutanoic acid

Ala Ile Gly Ile

(2S,3S)-2-{2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]acetamido}-3-methylpentanoic acid

Ala Ile Gly Leu

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]acetamido}-4-methylpentanoic acid

Ala Ile Ile Gly

2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylpentanamido]acetic acid

Ala Ile Leu Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-4-methylpentanamido]acetic acid

Ala Ile Val Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]-3-methylbutanamido]propanoic acid

Ala Leu Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]propanamido]-3-methylbutanoic acid

Ala Leu Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]acetamido}-3-methylpentanoic acid

Ala Leu Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]acetamido}-4-methylpentanoic acid

Ala Leu Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylpentanamido]acetic acid

Ala Leu Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-4-methylpentanamido]acetic acid

Ala Leu Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]-3-methylbutanamido]propanoic acid

Hydroxyprogesterone acetate

3,20-Dioxopregn-4-en-17-beta-yl acetate

Ala Val Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]propanamido]-3-methylpentanoic acid

Ala Val Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]propanamido]-4-methylpentanoic acid

Ala Val Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-methylpentanamido]propanoic acid

Ala Val Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-4-methylpentanamido]propanoic acid

Gly Ala Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-methylpentanamido]-3-methylpentanoic acid

Gly Ala Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-methylpentanamido]-4-methylpentanoic acid

Gly Ala Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-methylpentanamido]-3-methylpentanoic acid

Gly Ala Leu Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-methylpentanamido]-4-methylpentanoic acid

Gly Ile Ala Ile

(2S,3S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]propanamido]-3-methylpentanoic acid

Gly Ile Ala Leu

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]propanamido]-4-methylpentanoic acid

Gly Ile Ile Ala

(2S)-2-[(2S,3S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-methylpentanamido]propanoic acid

Gly Ile Leu Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-4-methylpentanamido]propanoic acid

Gly Leu Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]propanamido]-3-methylpentanoic acid

Gly Leu Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]propanamido]-4-methylpentanoic acid

Gly Leu Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-methylpentanamido]propanoic acid

Gly Leu Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-4-methylpentanamido]propanoic acid

Gly Val Val Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanoic acid

Leu Gln Ile

Ile Ala Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]propanamido]-3-methylbutanoic acid

Ile Ala Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]acetamido}-3-methylpentanoic acid

Ile Ala Gly Leu

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]acetamido}-4-methylpentanoic acid

Ile Ala Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylpentanamido]acetic acid

Ile Ala Leu Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-4-methylpentanamido]acetic acid

Ile Ala Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]-3-methylbutanamido]propanoic acid

Ile Gly Ala Ile

(2S,3S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}propanamido]-3-methylpentanoic acid

Ile Gly Ala Leu

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}propanamido]-4-methylpentanoic acid

Ile Gly Ile Ala

(2S)-2-[(2S,3S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-methylpentanamido]propanoic acid

Ile Gly Leu Ala

(2S)-2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-4-methylpentanamido]propanoic acid

Ile Ile Ala Gly

2-[(2S)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]propanamido]acetic acid

Ile Ile Gly Ala

(2S)-2-{2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]acetamido}propanoic acid

Ile Leu Ala Gly

2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]propanamido]acetic acid

Ile Leu Gly Ala

(2S)-2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]acetamido}propanoic acid

Arg Val Val

Ile Val Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]propanamido]propanoic acid

Ile Leu Lys

Val Val Arg

Gln Ile Leu

Leu Leu Lys

Leu Ala Ala Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]propanamido]-3-methylbutanoic acid

Leu Ala Gly Ile

(2S,3S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]acetamido}-3-methylpentanoic acid

Leu Ala Gly Leu

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]acetamido}-4-methylpentanoic acid

Leu Ala Ile Gly

2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylpentanamido]acetic acid

Leu Ala Leu Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-4-methylpentanamido]acetic acid

Leu Ala Val Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-methylbutanamido]propanoic acid

Leu Lys Leu

Lys Leu Leu

Leu Gly Ala Ile

(2S,3S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}propanamido]-3-methylpentanoic acid

Leu Gly Ala Leu

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}propanamido]-4-methylpentanoic acid

Leu Gly Ile Ala

(2S)-2-[(2S,3S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-methylpentanamido]propanoic acid

Leu Gly Leu Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-4-methylpentanamido]propanoic acid

Leu Ile Ala Gly

2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]propanamido]acetic acid

Leu Ile Gly Ala

(2S)-2-{2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]acetamido}propanoic acid

Leu Leu Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]propanamido]acetic acid

Leu Leu Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]acetamido}propanoic acid

Leu Ile Lys

Ile Gln Leu

Leu Val Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]propanamido]propanoic acid

Leu Lys Ile

Ile Lys Leu

Leu Gln Leu

Gln Leu Ile

Lys Ile Leu

Ile Ile Gln

Leu Leu Gln

Lys Leu Ile

Gln Leu Leu

Ile Leu Gln

Leu Ile Gln

Ile Ile Lys

Val Ala Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]propanamido]-3-methylpentanoic acid

Val Ala Ala Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]propanamido]-4-methylpentanoic acid

Val Ala Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-methylpentanamido]propanoic acid

Val Ala Leu Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-4-methylpentanamido]propanoic acid

Val Gly Val Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-methylbutanamido]-3-methylbutanoic acid

Val Ile Ala Ala

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]propanamido]propanoic acid

Val Leu Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]propanamido]propanoic acid

Val Val Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]acetamido}-3-methylbutanoic acid

Val Val Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-3-methylbutanamido]acetic acid

Proscar

(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

19(R)-hydroxy-PGF1&alpha

9S,11R,15S-19R-tetrahydroxy-13E-prostaenoic acid

13,14-dihydro-19(R)-hydroxyPGE1

9-oxo-11R,15S,19R-trihydroxy-prostanoic acid

(5Z,7E)-(3S)-3-hydroxy-9,10-seco-5,7,10(19)-cholatrien-24-oic acid

cholacalcioic acid / 25,26,27-trinorvitamin D3 24-carboxylic acid / 25,26,27-trinorcholecalciferol 24-carboxylic acid

3-oxochol-4-en-24-oic acid

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

3-Oxo-5β-chol-1-en-24-oic Acid

(22E)-3β-Hydroxy-5α-chola-7,22-dien-24-oic Acid

3-Oxo-5β-chol-9(11)-en-24-oic Acid

3-Oxo-5β-chol-14-en-24-oic Acid

3-Oxo-5β-chol-7-en-24-oic Acid

3α-Hydroxy-5β-chola-8,14-dien-24-oic Acid

(20S,22E)-3β-Hydroxychola-5,22-dien-24-oic Acid

(22E)-3β-Hydroxychola-5,22-dien-24-oic Acid

3α-Hydroxy-5β-chola-8(14),11-dien-24-oic Acid

3α-Hydroxy-5β-chola-7,9(11)-dien-24-oic Acid

(22E)-3β-Hydroxy-5α-chola-16,22-dien-24-oic Acid

3-Oxo-5β-chol-8-en-24-oic Acid

3-Oxo-5β-chol-8(14)-en-24-oic Acid

3-Oxo-5β-chol-6-en-24-oic Acid

3-Oxo-5β,14β-chol-8-en-24-oic Acid

3β-Hydroxychola-5,7-dien-24-oic Acid

3β-Hydroxychola-5,16-dien-24-oic Acid

(20S)-3β-Hydroxychola-5,16-dien-24-oic Acid

3-OXO-CHOL-11-ENIC ACID

3-ACETOXYPREGN-16-EN-12,20-DIONE

15(R),19(R)-hydroxy Prostaglandin F1&alpha

9α,11α,15R,19R-tetrahydroxy-prost-13E-en-1-oic acid

(+)-Dysideapalaunic acid

3beta-Hydroxychola-5,16-dien-24-oic Acid

(20S)-3beta-Hydroxychola-5,16-dien-24-oic Acid

Nabilone

(−)-nabilone

A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics

Scutigeral

2,3,4-trihydroxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]benzaldehyde

Neriantogenin

4-{5,12-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-13-en-14-yl}-2,5-dihydrofuran-2-one

5-Ethoxysorgoleone 358

5-ethoxy-2-hydroxy-3-[(8E,11E)-pentadeca-8,11,14-trien-1-yl]cyclohexa-2,5-diene-1,4-dione

1-Benzoyl-2-octadecanone

1-phenylnonadecane-1,3-dione

5-(10,13-Nonadecadienyl)resorcinol

5-[(10E,13E)-nonadeca-10,13-dien-1-yl]benzene-1,3-diol

8-hydroxy-3-[(6E)-pentadec-6-en-1-yl]-3,4-dihydro-1H-2-benzopyran-1-one

(3R, 6'Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one

11-dehydro Thromboxane B2-d4

C20H28D4O6 (372.244985912)

FA 25:5

19-phenyl-15E-nonadecenoic acid

FA 20:2;O4

9S,11R,15S,19R-tetrahydroxy-13E-prostaenoic acid

C20H40N2O4 (372.29879200000005)

11-dehydro-TXB2-d4

9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid-d4

C20H28D4O6 (372.244985912)

alpha-N-(3-hydroxy-13-methyl-tetradecanoyl)-ornithine

5-amino-2-(3-hydroxy-13-methyl-tetradecanamido)pentanoic acid

ascr#23

13R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tetradecenoic acid

An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E,13R)-13-hydroxytetradec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

oscr#23

14-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-tetradecenoic acid

An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (2E)-14-hydroxytetradec-2-enoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

ST 25:2;O2

3beta-hydroxy-26,27-bisnorcholest-5-en-24-one

Cholacalcioic acid

(5Z,7E)-(3S)-3-hydroxy-9,10-seco-5,7,10(19)-cholatrien-24-oic acid

ST 24:3;O3

(22E)-3beta-Hydroxy-5alpha-chola-16,22-dien-24-oic Acid

D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

Polycerasoidin

9-[(2R)-6-methoxy-2,8-dimethyl-3,4-dihydrochromen-2-yl]-2,6-dimethylnona-2E,6E-dienoic acid

(Z)-1-(3-hydroxyphenyl)nonadec-9-en-2-one

5-((8Z,11Z)-nonadeca-8,11-dien-1-yl)resorcinol

5-((8Z,11Z)-nonadeca-8,11-dien-1-yl)benzene-1,3-diol

17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one

Dicyclohexyl 18-crown-6

2(3)-(tetrahydrofurfuryloxy)tetrahydropyran

C18H37NaO4S (372.23101220000007)

sodium n-octadecyl sulfate

1,3-DI(ADAMANTAN-1-YL)-1H-IMIDAZOL-3-IUM CHLORIDE

C23H33ClN2 (372.23321280000005)

(S)-α-Azidobenzenepropanoic acid (dicyclohexylammonium) salt

C21H32N4O2 (372.25251319999995)

(1R,3R,4S)-4-((TERT-BUTYLDIMETHYLSILYL)OXY)-3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-2-METHYLENECYCLOPENTANOL

C19H40O3Si2 (372.251585)

tert-butyl 4-(3,3-diethyl-2-oxoindol-1-yl)piperidine-1-carboxylate

C22H32N2O3 (372.2412802)

(E)-1,2-DIBROMO-1,2-BIS-TRIMETHYLSILANYL-ETHENE

C18H38B2O6 (372.2854348)

1-(1-ethynylcyclohexyl)oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol

C22H32N2O3 (372.2412802)

2-Thiazolamine,4-phenyl-5-tetradecyl-

C23H36N2S (372.2599056)

1-Testosterone tetrahydropyran

C21H37ClO3 (372.24310820000005)

rac-1-Linoleoyl-3-chloropropanediol

N,Nμ-Bis(4-butylphenyl)benzene-1,4-diamine

C26H32N2 (372.2565352)

Norgestomet

Norprogesterone

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

Glycerides, C8-10

(3aR,4S,5R,6aS)-4-((tert-butyldimethylsilyloxy)methyl)-5-(tetrahydro-2H-pyran-2-yloxy)hexahydro-2H-cyclopenta[b]furan-2-ol

C19H36O5Si (372.2331886)

LAURAMIDOBUTYL GUANIDINE HCl

C19H40N4O3 (372.310025)

5-HYDROXYINDOLE-3-ACETIC ACID DICYCLOHEXYLAMMONIUM SALT

C22H32N2O3 (372.2412802)

1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics

Decanoic acid, 1-(hydroxymethyl)-2-((1-oxooctyl)oxy)ethyl ester

(2E,13R)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

(2E)-14-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradec-2-enoic acid

Anagestone acetate

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

H-Leu-Lys-Leu-OH

2,4-Dihydroxy-6-methyl-3-((2E)-3-methyl-5-((1S,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl)-2-penten-1-yl)benzaldehyde

1-(Acetyloxy)-3-hydroxypropan-2-YL hexadecanoate

3,20-Dioxopregn-4-en-11-yl acetate

Tocris-0567

(6aS,9R,10R,10aS)-9-ethenyl-10-isocyano-6,6,9-trimethyl-1-(2-methylbut-3-en-2-yl)-2,6,6a,7,8,9,10,10a-octahydronaphtho[1,2,3-cd]indole

C26H32N2 (372.2565352)

(4Z,8Z,12Z,16Z)-4,8,12,16-tetramethyl-20-oxohenicosa-4,8,12,16-tetraenal

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethyl-dimethylazanium

C26H30NO+ (372.232727)

1,2-Dioctanoyl-3-methyl-1,2,3-butanetriol

(3-Carboxy-2-tetradecanoyloxypropyl)-trimethylazanium

[3-Carboxy-2-(12-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(4-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(11-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(5-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(8-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(7-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(6-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(9-methyltridecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(10-methyltridecanoyloxy)propyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-9-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-2-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-7-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-8-enoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(E)-11-carboxyundec-6-enoyl]oxypropyl]-trimethylazanium

C20H38NO5+ (372.27498380000003)

[3-Carboxy-2-(3-oxotridecanoyloxy)propyl]-trimethylazanium

(1S,9aR,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

Leu-Gln-Leu

acetic acid [(3S,5S,10S,13S)-17-acetyl-10,13-dimethyl-12-oxo-1,2,3,4,5,6,7,8,9,11,14,15-dodecahydrocyclopenta[a]phenanthren-3-yl] ester

(3beta,9xi)-3,14-Dihydroxycarda-5,20(22)-dienolide

1-[1-(1-Cyclopentyl-5-tetrazolyl)-2-methylpropyl]-4-(2-fluorophenyl)piperazine

C20H29FN6 (372.2437606)

3alpha-Hydroxy-5beta-pregn-16-ene-11,20-dione 3-acetate

Ile-Gln-Ile

Leu-Ile-Lys

Leu-Leu-Gln

Lys-Ile-Leu

Leu-Leu-Lys

6-(Dimethylamino)-2-{4-[4-(dimethylamino)phenyl]buta-1,3-dien-1-yl}-1-ethylquinolinium

C25H30N3+ (372.24396)

3,14-Dihydroxycarda-5,20(22)-dienolide

2,4-Dihydroxy-3-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]-6-(hydroxymethyl)benzaldehyde

(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-17-[(2R)-5-hydroxypentan-2-yl]-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one

Gln-Ile-Ile

Ile-Ile-Gln

Ile-Leu-Gln

Ile-Leu-Lys

Leu-Gln-Ile

Leu-Ile-Gln

Lys-Leu-Ile

Ile-Lys-Ile

Val-Val-Arg

Gln-Ile-Leu

Ile-Lys-Leu

Arg-Val-Val

Gln-Leu-Ile

Gln-Leu-Leu

Ile-Gln-Leu

Ile-Ile-Lys

Leu-Lys-Ile

Lys-Ile-Ile

Lys-Leu-Leu

Val-Arg-Val

(1S,3aS,3bR,5aR,9aR,9bR,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

[(2R)-3-carboxy-2-tetradecanoyloxypropyl]-dimethyl-(trideuteriomethyl)azanium

Glycerin 1,2-dipelargonate

(1-Hexanoyloxy-3-hydroxypropan-2-yl) dodecanoate

(1R,3aS,3bS,5aR,9aR,9bR,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide

Progesterone 3,20-bis(O-methyloxime)

1-Tetradecyl-2,3-DI-O-acethyl glycerol

(4R)-1-Acetoxy-4-(tert-butyldimethylsilyloxy)-5-pivaloyloxyhexene

C19H36O5Si (372.2331886)

Ethyl (4R,5R)-(E)-4-(2-tetrahydropyranyl)oxy-5-(tert-butyldimethylsilyl)oxy-2-hexenoate

Ethyl (4R*,5R*)-(E)-4-(2-tetrahydropyranyl)oxy-5-(tert-butyldimethylsilyl)oxy-2-hexenoate

C19H36O5Si (372.2331886)

(4AS,5S,8AS)-E-(+)-3-Methyl-5-((5alpha-(4-methyl-3-pentenyl)-2,5beta,8abeta,trimethyl-3,4,4A,5,6,7,8,8A-octahydronaphthalenyl))-2-pentenoic acid

(1-Hydroxy-3-pentanoyloxypropan-2-yl) tridecanoate

(1-Butanoyloxy-3-hydroxypropan-2-yl) tetradecanoate

(1-Heptanoyloxy-3-hydroxypropan-2-yl) undecanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) pentadecanoate

Gentian violet cation

C25H30N3+ (372.24396)

Cervonoyl ethanolamide

[(2S)-1-hydroxy-3-octanoyloxypropan-2-yl] decanoate

(2S)-3-hydroxy-2-(octanoyloxy)propyl decanoate

9-Carboxy-gamma-tocotrienol

[(2R)-2-hydroxy-3-octanoyloxypropyl] decanoate

19R-hydroxy-PGF1alpha

13,14-dihydro-19R-hydroxyPGE1

3beta-Hydroxychola-5,7-dien-24-oic Acid

3alpha-Hydroxy-5beta-chola-8,14-dien-24-oic Acid

19-phenyl-15E-nonadecenoic acid

3-Oxo-5beta-chol-1-en-24-oic Acid

3-Oxo-5beta-chol-9(11)-en-24-oic Acid

(20S,22E)-3beta-Hydroxychola-5,22-dien-24-oic Acid

3alpha-Hydroxy-5beta-chola-7,9(11)-dien-24-oic Acid

3alpha-Hydroxy-5beta-chola-8(14),11-dien-24-oic Acid

(22E)-3beta-Hydroxy-5alpha-chola-7,22-dien-24-oic Acid